ロード中...
The changing multiple sclerosis treatment landscape: impact of new drugs and treatment recommendations
PURPOSE: The purpose of this study is to describe the utilization of disease-modifying treatments (DMTs) in relapsing-remitting multiple sclerosis (MS) and assess the impact of both the introduction of new drugs and treatment recommendations (local recommendation on rituximab use issued at the large...
保存先:
| 出版年: | Eur J Clin Pharmacol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5893684/ https://ncbi.nlm.nih.gov/pubmed/29429031 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00228-018-2429-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|